Corrigendum to “Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure” 65 (2015) 526–530 6 (Journal of Cardiology (2015) 65(6) (526–530), (S0914508714002664), (10.1016/j.jjcc.2014.08.012));Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure

Journal of Cardiology

Volumn 65, Issue 6, 2015, Pages 526-530

  Shionimya, Haruki ^a   Koyama, Satoshi ^a   Tanada, Yohei ^a   Takahashi, Naoki ^a   Fujiwara, Hisayoshi ^a   Takatsu, Yoshiki ^a   Sato, Yukihito ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

Cardiac troponin; Heart failure; Hemodynamics; Left ventricular ejection fraction; Left ventricular end diastolic pressure

Indexed keywords

ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HEMOGLOBIN; HEMOGLOBIN A1C; RENIN; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE STENOSIS; PROTEIN BLOOD LEVEL; VERY ELDERLY; BLOOD; BLOOD PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TROPONIN T; VENTRICULAR FUNCTION, LEFT;

EID: 84929511887     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2021.11.007     Document Type: Erratum

References (22)

1. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., Biedert S., Schaub N., Buerge C., Potocki M., Noveanu M., Breidthardt T., Twerenbold R., Winkler K., Bingisser R., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
2. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., Angelici L., Barlera S., Parrinello G., Maggioni A.P., Tognoni G., Cohn J.N., Val-HeFT Investigators Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
3. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., Kataoka K., Ito H., Matsumori A., Sasayama S., Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
4. Peacock W.F., De Marco T., Fonarow G.C., Diercks D., Wynne J., Apple F.S., Wu A.H., ADHERE Investigators Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126.
5. Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
6. Eggers K.M., Nygren M., Venge P., Jernberg T., Wikström B.G. High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension. Clin Chim Acta 2011, 412:1582-1588.
7. Ralli S., Horwich T.B., Fonarow G.C. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J 2005, 150:1220-1227.
8. Nishio Y., Sato Y., Taniguchi R., Shizuta S., Doi T., Morimoto T., Kimura T., Kita T. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure. Circ J 2007, 71:631-635.
9. Sato Y., Miyamoto T., Taniguchi R., Nagao K., Matsuoka T., Fukuhara R., Kuwabara Y., Isoda K., Yamane K., Nishi K., Saijyo S., Fujiwara H., Takatsu Y. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST. J Cardiol 2009, 53:20-27.
10. Sato Y., Fujiwara H., Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol 2012, 60:160-167.
11. De Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., Hashim I., Berry J.D., Das S.R., Morrow D.A., McGuire D.K. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
12. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., Tjora S., Domanski M.J., Gersh B.J., Rouleau J.L., Pfeffer M.A., Braunwald E., Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
13. Masson S., Anand I., Favero C., Barlera S., Vago T., Bertocchi F., Maggioni A.P., Tavazzi L., Tognoni G., Cohn J.N., Latini R., Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca - Heart Failure (GISSI-HF) Investigators Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure clinical perspective. Circulation 2012, 125:280-288.
14. Fertin M., Hennache B., Hamon M., Ennezat P.V., Biausque F., Elkohen M., Nugue O., Tricot O., Lamblin N., Pinet F., Bauters C. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am J Cardiol 2010, 106:1410-1416.
15. Aarones M., Gullestad L., Aakhus S., Ueland T., Skaardal R., Aass H., Wergeland R., Smith H.J., Aukrust P., Kongsgaard E. Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy. Am Heart J 2011, 161:1031-1037.
16. Sato Y., Nishi K., Taniguchi R., Miyamoto T., Fukuhara R., Yamane K., Saijyo S., Tanada Y., Yamamoto E., Goto T., Takahashi N., Fujiwara H., Takatsu Y. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 2009, 54:221-230.
17. Freda B.J., Tang W.H.W., Van Lente F., Peacock W.F., Francis G.S. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002, 40:2065.
18. Tsutamoto T., Kawahara C., Yamaji M., Nishiyama K., Fujii M., Yamamoto T., Horie M. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur J Heart Fail 2009, 11:653-658.
19. Diris J.H., Hackeng C.M., Kooman J.P., Pinto Y.M., Hermens W.T., van Dieijen-Visser M.P. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004, 109:23-25.
20. Takashio S., Yamamuro M., Izumiya Y., Sugiyama S., Kojima S., Yamamoto E., Tsujita K., Tanaka T., Tayama S., Kaikita K., Hokimoto S., Ogawa H. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure. J Am Coll Cardiol 2013, 62:632-640.
21. Gheorghiade M., De Luca L., Fonarow G.C., Filippatos G., Metra M., Francis G.S. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 2005, 96:11-17.
22. Hessel M.H.M., Atsma D.E., Valk E.J.M., Bax W.H., Schalij M.J., Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 2007, 455:979-986.